Alymsys
Analogs of Alymsys
Find cheaper analogs and generic equivalents for Alymsys.
Active Ingredient: bevacizumab
Product Overview
About Alymsys
Alymsys is a prescription medicine that should be supervised by a doctor who has experience in the use of cancer medicines.
What it is used for
Alymsys is used to treat cancer.
How it is used
Alymsys is given by infusion (drip) into a vein. The first infusion of Alymsys should last 90 minutes, but subsequent infusions may be given more quickly if the earlier infusion has not caused unacceptable side effects. The dose depends on the patient’s weight, the type of cancer being treated and the other cancer medicines being used. Treatment is continued for as long as the patient benefits from it. The doctor may interrupt or stop treatment if the patient develops certain side effects.
How it works
The active substance in Alymsys, bevacizumab, is a monoclonal antibody (a type of protein) that has been designed to attach to vascular endothelial growth factor (VEGF), a protein that circulates in the blood and makes new blood vessels grow. By attaching to VEGF, Alymsys stops its effect. As a result, the cancer cannot develop its own blood supply and cancer cells are starved of oxygen and nutrients, helping to slow down the growth of tumours.
Active substance: bevacizumab
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
